Aushon Launches New SignaturePLUS™ System for Multiplex Protein Biomarker Analysis
Aushon has announced the global launch of its next generation SignaturePLUS™ Imaging and Analysis System. The SignaturePLUS system is designed to meet the cost and performance needs of researchers for accurate, reproducible, and reliable multiplex protein biomarker analysis across pre-clinical, clinical and diagnostics applications in all therapeutic areas.
The SignaturePLUS™system incorporates an advanced CCD imager with custom optics designed specifically for quantitative chemiluminescent protein arrays. Its sleek, compact design uses less than 2 feet of bench space and includes an integrated iPad® user interface with an embedded Mac mini® computer that eliminates the need for separate, bulky system components. The SignaturePLUS system also includes the enhanced PROarray® Analyst software for fast, accurate, reproducible analysis.
Engineered for simple, out-of-the-box setup, the SignaturePLUS system is extremely easy to use and features typical imaging times of less than 2 minutes per plate.
Aushon’s multiplex platform was recently validated in multiple late stage clinical trials and showed excellent correlation with the traditional single-plex ELISA, yet demonstrated all the advantages associated with multiplexing including significantly reduced sample consumption, lower cost per data point, and a substantial increase in overall lab productivity.
Researchers can choose from Aushon’s growing menu of more than 300 validated protein biomarkers for analysis using the new SignaturePLUS system.